Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | EYA2 | O00167 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6883006 | 0.90 | TDP1 (0.70) | TDP1EYA2APPACETSHR | |
| Nitrilotriacetic Acid SCHEMBL8463064 | 0.82 | TDP1 (0.73) | TDP1EYA2APPACETSHR | |
| Nitrilotriacetic Acid SCHEMBL670055 | 0.82 | TDP1 (0.73) | TDP1EYA2APPACETSHR | |
| Nitrilotriacetic Acid SCHEMBL9771757 | 0.82 | TDP1 (0.73) | TDP1EYA2APPACETSHR | |
| Nitrilotriacetic Acid SCHEMBL20409 | 0.82 | TDP1 (0.73) | TDP1EYA2APPACETSHR | |
| SCHEMBL14046418 | 0.81 | TDP1 (0.57) | TDP1EYA2APPACETSHR | |
| SCHEMBL14719931 | 0.79 | TDP1 (0.48) | TDP1EYA2APPACETSHR | |
| SCHEMBL645401 | 0.79 | TDP1 (0.48) | TDP1EYA2APPACETSHR | |
| Nitrilotriacetic Acid SCHEMBL23358713 | 0.78 | TDP1 (0.69) | TDP1EYA2APPACETSHR | |
| Nitrilotriacetic Acid SCHEMBL9064058 | 0.78 | TDP1 (0.69) | TDP1EYA2APPACETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109535026-B | Method for synthesizing tetraalkyl nitrilo acetic acid diacetyl amide compound | 国立研究开发法人日本原子力研究开发机构 | 2021-10-29 | — | — | CN | claimed |
| CN-109021500-B | Epoxy resin glass fiber reinforced plastic for four-wheel electric vehicle shell | 安徽佳龙车业有限公司 | 2021-04-09 | — | — | CN | claimed |
| US-6872317-B1 | Chelate-forming filter, process for producing the same, and method of purifying liquid using the filter | CHELEST CORPORATION AND CHUBU CHELEST CO., LTD. (JP) | 2005-03-29 | — | — | US | claimed |
| EP-1090668-B1 | CHELATE-FORMING FILTER, PROCESS FOR PRODUCING THE SAME | CHELEST CORP (JP) | 2004-07-28 | — | — | EP | claimed |
| EP-0962582-B1 | METAL CHELATE FORMING FIBER, PROCESS FOR PREPARING THE SAME, AND METHOD OF METAL ION SEQUESTRATION USING SAID FIBER | CHELEST CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| EP-1043316-B1 | Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy | S & H PHARM TECHNOLOGY CO LTD (CN) | 2002-10-16 | — | — | EP | claimed |
| US-6271250-B1 | Metal Glycididaagolc, and preparation and uses thereof | S&H PHARM TECHNOLOGY CO., LTD (CN) | 2001-08-07 | — | — | US | claimed |
| EP-1090668-A1 | CHELATE-FORMING FILTER, PROCESS FOR PRODUCING THE SAME, AND METHOD OF PURIFYING LIQUID WITH THE FILTER | Chelest Corporation (JP) | 2001-04-11 | — | — | EP | claimed |
| US-6156075-A | WATER TREATMENT AND POLLUTION CONTROL | CHELEST CORPORATION (JP) | 2000-12-05 | — | — | US | claimed |
| EP-1043316-A2 | Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy | S & H Pharm Technology Co. Ltd (CN) | 2000-10-11 | — | — | EP | claimed |
| EP-0962582-A1 | METAL CHELATE FORMING FIBER, PROCESS FOR PREPARING THE SAME, AND METHOD OF METAL ION SEQUESTRATION USING SAID FIBER | Chelest Corporation (JP) | 1999-12-08 | — | — | EP | claimed |
| JP-10183470-A | — | — | None | — | — | JP | disclosed |
| EP-4572800-B1 | TETRAZINES WITH IMPROVED PROPERTIES | TAGWORKS PHARMACEUTICALS B V (NL) | 2026-04-08 | — | — | EP | disclosed |
| EP-4572800-A1 | TETRAZINES WITH IMPROVED PROPERTIES | Tagworks Pharmaceuticals B.V. (NL) | 2025-06-25 | — | — | EP | disclosed |
| US-20250114489-A1 | MASKED IL12 PROTEIN | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2025-04-10 | — | — | US | disclosed |
| EP-0696295-A1 | CARBOXYLIC-ACID FUNCTIONAL POLYURETHANE POLYMERS AND THEIR USE IN MAGNETIC RECORDING MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-02-14 | — | — | EP | disclosed |
| WO-1994025500-A1 | CARBOXYLIC-ACID FUNCTIONAL POLYURETHANE POLYMERS AND THEIR USE IN MAGNETIC RECORDING MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-11-10 | — | — | WO | disclosed |
| US-5155227-A | Compounds for site-enhanced delivery of radionuclides | UNIVERSITY OF FLORIDA (US) | 1992-10-13 | — | — | US | disclosed |
| US-4963688-A | Compounds for site-enhanced delivery of radionuclides and uses thereof | UNIVERSITY OF FLORIDA (US) | 1990-10-16 | — | — | US | disclosed |
| US-4418208-A | EXTERNAL IMAGING OF THE HEPATOBILIARY SYSTEM | E. R. SQUIBB & SONS, INC. (US) | 1983-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114489-A1 | MASKED IL12 PROTEIN | IL2, IL18, IL15 | TDP1 4608/4885EYA2 3938/4885APP 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.